Literature DB >> 10482809

Developmental effects of in vivo and in vitro inhibition of nitric oxide synthase in neurons.

M Virgili1, B Monti, A LoRusso, M Bentivogli, A Contestabile.   

Abstract

The diffusible chemical messenger nitric oxide (NO) is involved in neuronal plasticity and it is, therefore, supposed to play a role in brain development. A shortage of NO during the critical period of brain maturation may theoretically have long-lasting consequences on the organization of the adult brain. We have performed in neonatal rats a chronic inhibition of the enzyme responsible for NO production, nitric oxide synthase (NOS), from postnatal day 3 to postnatal day 23, through administration of the competitive antagonist N-nitro-L-arginine methylester (L-NAME). The calcium-dependent catalytic activity resulted almost completely inhibited throughout the period of treatment and it took more than 4 days after its suspension to get a full recovery. The expression of the neuronal isoform of the enzyme (nNOS), revealed by immunoblotting, was unchanged during the treatment and after it. The histochemical reaction for NADPH diaphorase was reduced at the end of the treatment and recovered in concomitance with the recovery of the catalytic NOS activity. No gross structural alterations were detected in brain morphology. The levels of three neurotransmitter-related and one astrocytic marker were unchanged in the cerebellum, hippocampus and cortex of 60-day-old rats which had been neonatally treated. A similar lack of significant effects on neurochemical brain maturation was also noticed in a parallel series of experiments, in which a short pulse of NOS inhibition was performed at a critical prenatal time of brain development, from gestational day 14 to gestational day 19. In vitro, chronic exposure of cerebellar granule cells to L-NAME (500 microM) resulted in slight decrease of surviving neurons after 8 days in culture and in better resistance to the challenge of stressful culture conditions. The present results suggest that the basic plan of brain organization can be achieved despite an almost complete NOS inhibition during the maturation period. In vitro, NOS inhibition may bring to more pronounced consequences on neuronal viability and function.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10482809     DOI: 10.1016/s0006-8993(99)01750-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

Review 1.  Regulation of neuronal proliferation and differentiation by nitric oxide.

Authors:  Sarah M Gibbs
Journal:  Mol Neurobiol       Date:  2003-04       Impact factor: 5.590

Review 2.  Cerebellar granule cells as a model to study mechanisms of neuronal apoptosis or survival in vivo and in vitro.

Authors:  Antonio Contestabile
Journal:  Cerebellum       Date:  2002 Jan-Mar       Impact factor: 3.847

Review 3.  Neurotrophic effects of AMPA.

Authors:  Cristina Limatola
Journal:  Cerebellum       Date:  2004       Impact factor: 3.847

Review 4.  Role of nitric oxide in cerebellar development and function: focus on granule neurons.

Authors:  Antonio Contestabile
Journal:  Cerebellum       Date:  2012-03       Impact factor: 3.847

5.  Neuronal NOS Induces Neuronal Differentiation Through a PKCα-Dependent GSK3β Inactivation Pathway in Hippocampal Neural Progenitor Cells.

Authors:  Shin-Young Park; Min-Jeong Kang; Joong-Soo Han
Journal:  Mol Neurobiol       Date:  2016-09-13       Impact factor: 5.590

6.  Peroxynitrite is Involved in the Apoptotic Death of Cultured Cerebellar Granule Neurons Induced by Staurosporine, but not by Potassium Deprivation.

Authors:  Mauricio Olguín-Albuerne; José Miguel Ramos-Pittol; Angélica Coyoy; Carlos Patricio Martínez-Briseño; Guadalupe Domínguez; Julio Morán
Journal:  Neurochem Res       Date:  2015-12-23       Impact factor: 3.996

Review 7.  Neuronal nitric oxide synthase expression in cerebellar mutant mice.

Authors:  Louise C Abbott; Sang-Soep Nahm
Journal:  Cerebellum       Date:  2004       Impact factor: 3.648

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.